gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · CERTTechnologyPackaged Software

Certara, Inc. Common Stock (CERT)

$10.87+1.49%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$10.87▼ 7.09% in range
Nov 3, 2025Low $4.48 · High $11.70Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026

Certara closed at $10.87 on Nov 3, up 1.49%, 7.1% below its 52-week closing high. Volume of 1.9M shares was 0.73× its 20-day average (below normal).

Split-adjusted performance: +7.9% over one month, +75.9% over six months, -6.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $93.27M, up 1.0% from a year earlier, with a net margin of -59.3%.

Short interest was 25.7M shares at the Oct 15 settlement, down 7.3% from the prior report (22.9% of float, 8.4 days to cover).

Market cap$1.66B152.5M shares
Revenue · quarter$93.3M+1.0% YoY
Diluted EPS$-0.36—
P/E · TTM—P/S 4.1×
Net margin-59.3%Gross 62.3%
Dividend yieldNone
52-week range4.48 – 11.70−7.1% from high
Volume1.9M0.73× 20-day avg
Volatility · 60d49.3%Annualised
Short % of float22.9%8.5 days to cover
Net cash-$107.7MCash $184.1M
Next earnings—Not scheduled
Split-adjusted performance
1W −0.7%1M +7.9%3M +35.7%6M +75.9%YTD +23.4%1Y −6.5%3Y −11.4%5Y −72.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Packaged Software

Percentile among 173 companies (100 = best)

6-month momentum83
Revenue growth21
Net margin14
Value (low P/E)—
Size47

Industry medians: 6-month return +16.1%, revenue growth +13.2%, net margin 1.4%, P/E 41.9×.

Short interest

Details →
Shares short25.7M−7.3% vs prior
Days to cover8.5Settled Oct 15
% of float22.9%
Short vol. 10d47.7%of daily volume

Closest peers by size in Packaged Software

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CERTCertara$10.87+1.49%+75.9%+1.0%−59.3%—$1.66B
LIMENeutron Holdings$25.48+12.84%————$1.66BCompare
XZOExzeo Group$17.79−2.63%+3.1%—39.1%—$1.60BCompare
CXMSprinklr$6.71−2.47%+23.6%+0.8%3.3%67.3$1.56BCompare
PDFSPDF Solutions$42.19+8.26%−9.0%+18.9%6.9%178.2$1.78BCompare
PRGSProgress Software Corp (DE)$44.12−1.69%+51.8%−1.5%9.3%19.5$1.80BCompare
SOUNSoundHound AI$4.12+0.73%−54.9%+45.0%−69.2%—$1.83BCompare
MQMarqeta$17.80−4.40%−0.7%+17.0%4.1%183.7$1.85BCompare
AIC3.ai$11.54−0.09%+22.6%−25.5%−177.2%—$1.86BCompare

News about Certara

All news →
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the FirmGlobeNewswire Inc. · Jun 19, 2026▼ NegativeCertara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewswire Inc. · Jun 18, 2026▼ NegativeCERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law FirmGlobeNewswire Inc. · May 24, 2026▼ NegativeCERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsGlobeNewswire Inc. · May 18, 2026▼ NegativeCertara Strategic Business Divestiture Comes At Right Time, Says AnalystBenzinga · Apr 22, 2026▲ Positive

Quick answers

What does Certara do?
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines.
What is CERT's market cap?
$1.66B, based on the Nov 3 close of $10.87.
Does Certara pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CERT is sold short?
25.7M shares, 22.9% of float, as of Oct 15, 2026.
What sector is CERT in?
Technology, in the Packaged Software industry.

About Certara

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

HQ: Radnor, PA1,576 employeesListed Dec 11, 2020certara.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology